Midwest life science stocks sizzle in a tepid first quarter
Until recently, the 2007 stock market performance was nothing to write home about, with one notable exception, according to Yer Biotech Blues columnist Michael Rosen. Midwestern biotech stocks did so well that 18 stocks (72 percent) out of a basket of the top 25 stocks...